STAT3 and neoplasm: By modulating signaling pathways such as NF-κB and STAT3, specific miRNAs can influence the balance between pro-inflammatory M1 and anti-inflammatory M2 macrophage phenotypes, thereby affecting both the inflammatory response and anti-tumor immunity (158).